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  1 
Abstract 2 
 3 
The soil bacterium Pseudomonas putida is endowed with a central carbon metabolic network capable 4 
of fulfilling high demands of reducing power. This situation arises from a unique metabolic architecture 5 
that encompasses the partial recycling of triose phosphates to hexose phosphates–the so-called 6 
EDEMP cycle. In this article, the value of P. putida as a bacterial chassis of choice for contemporary, 7 
industrially-oriented metabolic engineering is addressed. The biochemical properties that make this 8 
bacterium adequate for hosting biotransformations involving redox reactions as well as toxic 9 
compounds and intermediates are discussed. Finally, novel developments and open questions in the 10 
continuous quest for an optimal microbial cell factory are presented at the light of current and future 11 
needs in the area of biocatalysis. 12 
13 
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Introduction 1 
 2 
Metabolic engineering seeks the use of our current knowledge about live systems for designing and 3 
creating new biological agents that can function as biofactories of value-added products [1,2]. In 4 
recent years, synthetic biology (SynBio) has supported this agenda by providing a wealth of tools and 5 
strategies for the rational design of predictable DNA circuits and biochemical devices [3]. One focus of 6 
this ambitious program is the design of genetic constructs containing the information necessary to 7 
synthesize the product(s) of interest from the corresponding substrate(s). Yet, such DNA constructs 8 
must deploy their encoded properties into suitable cells that act both as physical containers and as 9 
providers of the molecular machinery necessary for heterologous gene expression. This objective 10 
leads to the important concept of chassis [4], i.e., live platforms able to host and sustain the molecular 11 
transactions necessary for expressing the information encoded in purposeful DNA designs. 12 
 13 
The number of SynBio-related technological advances increased greatly over the years, enabling 14 
metabolic engineers to design and obtain robust biocatalysts for targeted production of different types 15 
of biomolecules [5•-8]. However, relatively less attention has been paid to selecting optimal microbial 16 
cells in which these biotransformations can be implanted–in particular for providing the right 17 
biochemical frame to obtain the desired product(s). Note that, as elegant and efficient the design of a 18 
SynBio genetic circuit may look on paper, only the background biochemical network and metabolic 19 
connectivity make its adequate operation possible. The importance of selecting new robust bacterial 20 
chassis is therefore a must to expand the number and scope of potentially useful biocatalysis and 21 
metabolic engineering endeavors. In contrast with this overarching purpose, we currently rely on a 22 
comparatively limited number of microorganisms to perform a continuously increasing number of 23 
practical applications. 24 
 25 
In this context, the relevant question is about the features required in an ideal, bacterial-based SynBio 26 
chassis. Alas, the physical and spatial shape of a bacterial cell, its genomic complement, and its 27 
default gene expression machinery are usually not enough to meet the challenge. An optimal chassis 28 
should also provide a distinct metabolic and biochemical milieu for fueling whatever the property of 29 
interest has been genetically implanted in it, an scenario that cannot be taken for granted a priori.   30 
31 
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Select what you need: essential and non-essential functions in a SynBio chassis 1 
 2 
Since ideal SynBio constructs should operate autonomously in respect to the whole cell it is desirable 3 
that the bacterial chassis holds the minimal information needed [i] to fulfill the basic biological 4 
functions of growth and maintenance and [ii] to run the necessary machinery to curb adverse 5 
conditions that can appear during biocatalysis. In other words, genes encoding non-essential genetic 6 
information for survival could be removed from the bacterial genome [9•], which leads to the notion of 7 
minimal bacterial genome (Box 1)–and also to the design of such genome de novo [10••]. It should be 8 
noted that the idea of basic biological function is dependent on the context in which it is discussed. 9 
Recent work on quantitative biology of Escherichia coli has shed new light on the complex 10 
interactions between DNA replication, transcription, and RNA translation [11••], but the essentiality 11 
and relevance of which is sometimes difficult to ascertain a priori. Also note that a genome is not 12 
simply a collection of relevant genes: an organization of the genes with respect to one another is 13 
needed [12-14]. In bacterial chromosomes, in which there is a single origin of replication (thereby 14 
marking the beginning of the replication), the terminus of the chromosome is usually located near half 15 
of the entire genome DNA [15,16]. Also, there is a preferred orientation of the important genes with 16 
respect to the orientation of the replication fork movement and the 3D architecture of the bacterial 17 
chromosome [17,18]. In other words, the construction of a minimal genomic chassis is not just a 18 
matter of trimming DNA off, but also of carefully selecting the regions in the chromosome in which 19 
such engineering is feasible. A bacterium with such minimal genome would be not only more 20 
predictable and easily controllable [19], but it should also display reduced interactions between the 21 
cellular machinery and the genetic construct, which could otherwise lead to the appearance of 22 
unexpected reactions or phenotypes [20,21]. The microorganism of choice should be also amenable 23 
to targeted genetic modifications, with low spontaneous genetic variability, and should be equipped 24 
with a robust metabolism to accommodate the bioreactions encoded in the genetic graft in time and 25 
space. Due to the current technological limitations to create completely artificial cells [22], a preferred 26 
microbial chassis must be obtained from bacterial species that have been domesticated and/or 27 
modified to work in the laboratory and the industry as well.  28 
 29 
A suite of microbial hosts have been considered for metabolic engineering endeavors; with E. coli, 30 
Bacillus, Corynebacterium, Streptomyces, and yeast as the most widespread platforms [23-27]. 31 
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Cyanobacteria are also useful for light- and CO2-fueled industrial bioprocesses [28]. The selection of 1 
a host obviously depends on the specific application intended. Alas, no single naturally-isolated 2 
bacterial strain possesses all the desired characteristics of the ideal SynBio chassis (Fig. 1). Soil 3 
bacteria, however, could satisfy many of these requirements because of the conditions they naturally 4 
face in niches in which they thrive, particularly in terms of stressful physicochemical surroundings. 5 
 6 
Pseudomonas putida as the starting point for a robust physical and metabolic SynBio chassis 7 
 8 
Bacteria are endowed with versatile metabolic lifestyles that allow them to adapt to changing 9 
conditions, some of them rather adverse (e.g., oxidative stress, temperature challenges, and osmotic 10 
perturbations). Such adaptability is intrinsically encoded in their metabolism: environmental bacteria 11 
isolated from contaminated soils, for instance, display [i] a broad collection of transporters and 12 
enzymes to catabolize many different (and structurally unrelated) carbon sources and [ii] a set of 13 
regulators that provide the flexibility to quickly adjust to different conditions. In the case of 14 
Pseudomonads, for instance, all the metabolic machinery is geared to generate the biomass 15 
precursors, energy, and reducing power necessary to ensure the survival of the organism in virtually 16 
any hostile environmental niche [29]. A particular example within this clade is the soil bacterium 17 
Pseudomonas putida. 18 
 19 
P. putida is an ubiquitous rhizosphere colonizer that belongs to the wide (if somewhat fuzzy) group of 20 
fluorescent Pseudomonas. P. putida KT2440 is the best-characterized saprophytic laboratory 21 
Pseudomonad, that has retained its ability to survive and thrive in the environment [30], for which the 22 
entire chromosome sequence is available since 2002 [31], and this genomic data has been recently 23 
revisited, further multiplying our knowledge about  this bacterium [32•]. This strain is a well-24 
established host for cloning and gene expression, displays solvent tolerance [33•], and is endowed a 25 
remarkable capability to degrade aromatic compounds, such as toluene or m-xylene [34], so it is 26 
considered a model organism for biodegradation studies and a production platform [35,36]. Also, P. 27 
putida presents a high tolerance to oxidative stress [37] that is of interest for several technical 28 
applications, such as biofuels production [38]. Such properties, together with a plethora of SynBio 29 
tools tailored for targeted genetic manipulations [39-42] and the availability of four genome-scale 30 
constraint-based metabolic models for in silico studies [32,43-45], position P. putida as one of the 31 
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preferred contemporary physical SynBio chassis [46]. Several industrial processes based on P. putida 1 
are currently being exploited for the production of fine chemicals (e.g., 2-quinoxalinecarboxylic acid, 2 
5-methylpirazine-2-carboxylic acid, chiral amines, and 4-[6-hydroxypyridin-3-yl]-4-oxobutyrate) [35], 3 
and rhamnolipids, terpenoids, non-ribosomal peptides, and polyketides are also in the industrial 4 
pipeline at different degrees of development [36]. P. putida has recently been proposed as an useful 5 
cell factory for the valorization of lignin [47], highly cross-linked phenolic polymers derived from 6 
vegetal biomass and a very difficult-to-degrade substrate [48••], a situation which qualifies as a harsh 7 
biotransformation as it has to be executed in the presence of a plethora of inhibitory compounds and 8 
highly reactive intermediates. The intrinsic heterogeneity of this polymer leads to complex mixtures of 9 
aromatic compounds after pre-treatment, depolymerization, and hydrolysis of lignin. P. putida strains 10 
have been also engineered to use these aromatic compounds as the substrate to produce 11 
biopolymers [48••], cis,cis-muconate and adipic acid [49], and commodity chemicals lactate and 12 
pyruvate [50]. Recent advances in targeted evolution of artificial enzymes [51], use of xeno-nucleic 13 
acids [52], and genome re-coding [53,54] will certainly pave the way for new and exciting 14 
developments. In the meantime, the broad applicability of this soil bacterium in sophisticated industrial 15 
bioprocesses (and, in general, the overall physiology of P. putida) stem from a set of unique 16 
biochemical capabilities, not only by the abundance of peripheral pathways for aromatic carbon 17 
substrate degradation but also in the very central routes involved in carbon metabolism. 18 
 19 
The atypical central carbon metabolism of Pseudomonas putida 20 
 21 
Building on the metaphor of microbial cells as computers making computers [55], one could identify a 22 
software (i.e., the recursive transfer and trapping of information) and a hardware (i.e., the physical 23 
machine that executes the software). In a bacterial cell, the dynamic coupling between these two 24 
main components is mediated by chemical interchange brought about by metabolism [56,57]. Yet, 25 
what is the bona fide definition of central carbon metabolism? This seemingly simple question accepts 26 
rather flexible answers that are dynamically changing over time–sometimes even differing from 27 
classical definitions found in biochemistry textbooks. The prevailing vision lists a number of metabolic 28 
pathways as the core carbon metabolism, such as those found in yeast or E. coli, including the 29 
Embden-Meyerhof-Parnas (EMP) pathway, the pentose phosphate (PP) pathway, the Entner-30 
Doudoroff (ED) pathway, and the tricarboxylic acid (TCA) cycle. These routes can be used in very 31 
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different ways (sometimes interconnected) depending on the organism considered, the prevailing 1 
environmental conditions, and the carbon source catabolized [58-60]. Using P. putida KT2440 as a 2 
model bacterium, Sudarsan et al. [61] challenged this classic meaning of central metabolism, 3 
indicating that this definition may be equivocal without proper experimental validation, since 4 
microorganisms adapt their metabolic machinery according to specific environmental conditions. 5 
Regardless of the carbon source and the metabolic steps used for its breakdown, central carbon 6 
metabolism includes the metabolic pathways necessary for the synthesis of the 12 known essential 7 
biomass precursors (Box 2). 8 
 9 
Within this framework, the genome of P. putida KT2440 contains all the genes encoding enzymes that 10 
make the three prominent catabolic pathways for sugars in bacteria: the ED pathway, the EMP 11 
pathway, and the PP pathway. A notable exception is the glycolytic enzyme 6-phosphofructo-1-12 
kinase, Pfk, that catalyzes the transformation of fructose-6-P to fructose-1,6-bisphosphate [62]. The 13 
absence of Pfk in P. putida immediately rule out the possibility of glucose degradation through the 14 
EMP pathway (a feature shared with few other microorganisms apart of Pseudomonas species, such 15 
as Shewanella oneidensis [63]). Glucose is transformed into 6-phosphogluconate through a series of 16 
convergent pathways [64], and this metabolite is processed almost exclusively (96%) through the Edd 17 
and Eda enzymes (i.e., the ED pathway) with only a very small fraction of about 4% entering the PP 18 
pathway. Edd transforms 6-phosphogluconate to 2-keto-3-deoxy-6-phosphogluconate, and then this 19 
intermediate is split by Eda into pyruvate and glyceraldehyde-3-P. ED metabolism is far more widely 20 
distributed in Nature than previously thought [65], the enzymes being highly conserved among 21 
bacterial and even archaeal species. Microorganisms as Rhodobacter capsulatus and E. coli run a 22 
linear ED pathway, only induced when the cells grow on particular carbon sources, and the prevalent 23 
idea based on many studies with Enterobacteria was that the ED pathway is a rather 'accessory' route 24 
for sugar degradation [66]. Interestingly, P. putida is also equipped with a dedicated ED pathway for 25 
sulfoquinovose [67•], a prominent source of organosulfur in Nature. 26 
 27 
By adopting a multi-omic approach, glycolysis has been recently demonstrated to operate cyclically in 28 
P. putida [68••]. The set of reactions which comprise the so-called EDEMP cycle (Box 1) includes the 29 
ED route, part of the EMP pathway (operating in a gluconeogenic mode, in the same way as when 30 
glycerol is used as the substrate [69,70]), and elements of the PP pathway. Specifically, part of the 31 
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pool of triose phosphates is recycled by the EDEMP cycle back to glucose-6-P (Fig. 2). Under 1 
balance growth conditions with glucose as the only carbon source, the EDEMP cycle mediates a 2 
recycling of ca. 10% of the triose phosphates generated by the ED pathway. The rest of the carbon 3 
skeletons is metabolized into acetyl-coenzyme A to produce biomass precursors and reducing 4 
equivalents through the TCA cycle. Growth experiments with P. putida mutants deficient in EDEMP 5 
cycle enzymes indicated that this operation is essential. Yet, apart from the explicit recycling of 6 
carbon structures (and the generation of intermediates such as fructose-1,6-bisphosphate, which 7 
could not be obtained otherwise [71]), the operation of a cyclic glycolysis has important consequences 8 
in the overall redox balance of P. putida, which has been shown to be quite robust [72••]. The core 9 
glycolytic metabolism is nested in a larger biochemical network that comprises, among other features, 10 
the tightly-regulated formation and hydrolysis of polyhydroxyalkanoates [73]. This unique metabolic 11 
architecture strengthens the biochemical pillar of the ideal chassis in which SynBio grafts are to be 12 
implanted (see Box 1). 13 
 14 
Metabolism, resistance to oxidative stress, and bacterial lifestyle 15 
 16 
The EDEMP cycle of P. putida plays a role in adjusting NADPH synthesis to sustain anabolic 17 
demands and to provide endurance to oxidative stress [37]. Other cellular processes that consume 18 
NADPH include the recycling of methionine sulfoxides, oxidized forms of methionine known to result 19 
in protein deactivation, membrane damage, and cell ageing [74]. In particular, the major 20 
dehydrogenases in the EDEMP cycle of strain KT2440, such as glucose-6-P dehydrogenase (Zwf), 21 
are directly coupled to the formation of NADPH [75], with a small degree of promiscuity in cofactor 22 
selectivity [68]. In a linear ED pathway, one NADPH molecule is generated per molecule of glucose-6-23 
P entering the process through Zwf. In the EDEMP cycle, in contrast, the yield of NADPH can 24 
increase significantly depending on the extent of recycling (Fig. 3). The importance of Zwf in P. putida 25 
is manifested by the presence of three isozymes: Zwf-1 (PP_1022), Zwf-2 (PP_4042), and Zwf-3 26 
(PP_5351). Despite multiple attempts, a mutant lacking the three isoenzymes could not been 27 
obtained so far, perhaps as an indication of the essential character of this reaction. The NADPH 28 
balance in P. putida KT2440 growing on glucose is characterized by a slight catabolic overproduction 29 
of reducing power; however, the extent of cycling through the EDEMP cycle depends on specific 30 
environmental conditions. Specifically, the amount of NADPH formed depends on the partition of 31 
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glucose between phosphorylation and oxidation (Fig. 3). Such flexibility allows for the implementation 1 
of metabolic engineering strategies altering the overall redox balance of the cell, e.g., moving the 2 
lifestyle of P. putida from aerobiosis to anoxia [76-78]. 3 
 4 
Beyond Pseudomonas: The quest for the perfect bacterial chassis 5 
 6 
The physiological and metabolic properties discussed in the preceding sections argue for the 7 
selection of Pseudomonads as one starting point for constructing reliable SynBio platforms. Yet, the 8 
field of microbial cell factories is rapidly moving forward and the quest for the optimal chassis (or a 9 
panel of different chassis based on other microorganisms) continues. To this end, there are some 10 
issues that are very often overlooked–potentially affecting not only Pseudomonas–and that should 11 
frame the way metabolic engineers program any given cell factory. Some of such issues are briefly 12 
enunciated below. 13 
 14 
A first challenge is cell ageing. The rosy picture of microbial cell factories is that they remain stable for 15 
a long time, running a maintenance metabolism with a grafted SynBio implant that results in 16 
production of a metabolite or material of industrial interest. Alas, besides the inevitable carbonylation 17 
of proteins due to oxidative stress in vivo [79], the simple passing of time conduces to cell ageing and 18 
an alteration of their biocatalytic performance [56,80]. Specifically, proteins age because of intrinsic 19 
clocks mediated by aspartate and asparagine residues (among other mechanisms [81,82]), making 20 
them to aggregate or to be cleaved by proteases [83-85]–particularly under stressful conditions [86]. A 21 
detailed exploration of this often-neglected phenomenon, especially in industrial setups (e.g., in 22 
biotransformations) that re-use the same batch of biocatalyst cells to run a target substrate-to-product 23 
conversion), is a necessary step towards full cell programmability.  24 
 25 
A second question (and possibly a general bottleneck for metabolic engineering) is the spatial 26 
organization of bacterial metabolism [87••-89]. During normal growing conditions, a cell needs to 27 
prepare to build up a similar (i.e., daughter) structure. In an industrial setup, this situation is even 28 
more relevant, e.g., in a continuous cultivation in which bacteria are kept growing exponentially. Since 29 
the source of genetic information is located in the chromosomal DNA, there should exist some link 30 
between the 3D organization of the genes, the location of their products, and the connectivity between 31 
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the enzymes within a pathway [90]. The dichotomy soft-or-hard structures may endow cells with the 1 
ability to enter a control layer based on what one could call molecular fluidics, akin to microfluidics but 2 
ruled by a different physics. Fluidic channels could form not by assembly of physical pipes but by 3 
liquefaction of parts of a glass-like structure [91], or even by an asymmetric distribution of water (and 4 
therefore, metabolites) within the cell. Metabolism, again, lies at the core of this type of process: ca. 5 
70% of water in the cell results come from biochemical reactions. Many of these reactions are actually 6 
driven by water usage (e.g., hydrolysis) or production (e.g., polymerization of macromolecules). This 7 
situation can be manipulated to boost the formation of a metabolite by considering the physical space 8 
at which the molecule is produced and consumed. Again, these are features of metabolic engineering 9 
that tend to be ignored in most whole-cell biocatalysis designs. 10 
 11 
Finally, and in close connection with the concept of metabolic channeling in the bacterial cytoplasm, 12 
one could envision a setup in which the actual macroscopic shape of the cells (or their social 13 
behavior) is modified to enhance a given catalytic output, a trait that qualifies as synthetic morphology 14 
[92,93]. By targeting, for instance, the ability of cells to aggregate in biofilms, one could boost the 15 
biochemical properties of individual bacterial cells, such as the biodegradation of a target molecule 16 
[94•]. These artificially-designed spatial arrangements can be considered an integral part of the 17 
design of the ultimate physical SynBio chassis for biocatalysis [95]. 18 
 19 
SynBio has enriched the field of metabolic engineering not only by providing a wealth of genome-20 
editing tools, DNA assembly methods, and modeling of complex biochemical networks, but also by 21 
pinpointing new fundamental questions and technological opportunities that will keep the community 22 
busy for quite a few years to come. The issues enumerated in the last section of this review are of 23 
special interest as they have been mostly neglected in most classical metabolic engineering designs, 24 
and some progress is expected in the near future. In particular, new model bacteria will provide 25 
mechanistic insights to these problems from a different perspective than in well-established platforms 26 
such as E. coli. 27 
28 
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Boxes 1 
 2 
Box 1. A glossary of Synthetic Biology- and metabolic engineering-related jargon relevant to the 3 
design of microbial cell factories. 4 
  5 
Chassis A live platform in which the user plugs-in and -out heterologous genetic 
constructs. The term is taken from car engineering and it evokes the internal 
framework supporting a man-made object. Chassis embodies at least 4 
different aspects: [i] the physical container of the genetic constructs, [ii] The 
genomic skeleton and the cellular machinery necessary for heterologous 
gene expression, [iii] the biochemical network in which the activities 
encoded by the gene implant are nested, and [iv] the spatial scaffold for the 
genetic and metabolic graft to take place in space and time. 
Orthogonality This concept entails the autonomy of any implanted component (e.g., genetic 
or metabolic) with respect to the extant cell genetics and physiology. 
Orthogonality is a requisite for programmability, a desirable trait in any 
microbial cell factory in which the implanted components can be externally 
controlled in a context-independent fashion. 
Minimal genome The genetic complement of a cell in which the individual components are 
modified such as the only remaining functions are those strictly necessary for 
replication and maintenance (and probably resistance to stress). Note that the 
elements needed for these functions also depend on environmental 
conditions. 
EDEMP cycle A novel metabolic architecture of Pseudomonas putida encompassing 
activities belonging to the Entner-Doudoroff, the Embden-Meyerhof-Parnas, 
and the pentose phosphate pathways. The operation of this cycle enables the 
bacterium to recycle part of the carbon source (from trioses phosphate to 
hexoses phosphate) and to adjust NADPH formation. 
Synthetic 
Morphology 
The targeted modification of the cell shape or social behavior in response to 
the implantation of a dedicated genetic circuit. 
6 
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Box 2. The 12 precursor metabolites of central carbon metabolism in bacteria. 1 
  2 
Metabolite 
Metabolic pathway from  
which it derives 
Building block(s) obtained from it 
Glucose-6-P 
Embden-Meyerhof-Parnas 
pathway 
Lipopolysaccharides, glycogen 
Fructose-6-P Cell wall constituents 
Glyceraldehyde-3-P Lipids 
Glycerate-3-P Cys, Gly, Ser 
Phosphoenolpyruvate Trp, Tyr 
Pyruvate Ala, Leu, Ile, Lys, Val 
Acetyl-coenzyme A Lipids, Leu 
Erythrose-4-P 
Pentose phosphate pathway 
Phe, Trp, Tyr 
Ribose-5-P  Nucleotides, His, Phe, Trp 
2-Ketoglutarate 
Tricarboxylic acid cycle 
Glu, Gln, Arg, Pro 
Succinyl-coenzyme A Tetrapyrroles, Met, Lys 
Oxaloacetate Nucleotides, Asp, Asn, Ile, Lys, 
Met, Thr 
 3 
The information on the fate of each metabolite is derived from Noor et al. [96]. Note that the shading 4 
for each of the metabolic pathways indicated is the same as depicted in Figure 2. 5 
  6 
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Figures 1 
 2 
Figure 1. Desirable characteristics in an ideal physical and metabolic Synthetic Biology 3 
chassis based on Pseudomonas. 4 
 5 
 6 
 7 
 8 
 9 
The figure sketches the journey of a Pseudomonas isolate from soil up to industrial production and 10 
summarizes the main traits needed in a chassis at the different levels of cellular organization: 11 
genomic, metabolic, and physiological. No naturally-occurring microorganism conforms with all the 12 
requirements in such ideal chassis, and Synthetic Biology and rational metabolic engineering help 13 
fulfilling these requirements. Note the cyclic nature of the manipulations needed to reach such 14 
objective. 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
24 
24 
 
 
 
Figure 2. Main pathways of the core Pseudomonas putida KT2440 metabolism. 1 
 2 
 3 
 4 
 5 
 6 
 7 
The catabolism of hexoses is organized around the EDEMP cycle [68], composed of activities from 8 
different metabolic blocks which are identified with colors. Abbreviations of the metabolites and 9 
enzymes in this metabolic map are as follows: Glk, glucokinase; G6P, glucose-6-P; 6PG, 6-10 
phosphogluconate; KDPG, 2-keto-3-deoxy-6-phosphogluconate; GnuK, gluconokinase; Gcd, glucose 11 
dehydrogenase; FBP, fructose-1,6-P2; Fbp, fructose-1,6-bisphosphatase; Pgi, G6P isomerase; Zwf, 12 
G6P dehydrogenase; Pgl, 6-phosphogluconolactonase; KguK, 2-ketogluconate kinase; KguD, 2-13 
ketogluconate-6-P reductase; Edd, 6PG dehydratase; Eda, KDPG aldolase; Fda, FBP aldolase; TpiA, 14 
triose phosphate isomerase; Gnd, 6PG dehydrogenase; PPs, pool of pentoses phosphate; Rpe, 15 
ribulose-5-P 3-epimerase; TktA, transketolase; Tal, transaldolase; RpiA, ribose-5-P isomerase; GA3P, 16 
glyceraldehyde-3-P; Gap, GA3P dehydrogenase; BPG, 1,3-bisphosphoglycerate; 3PG, glycerate-3-P; 17 
2PG, glycerate-2-P; Pgk, phosphoglycerate kinase; Pgm, phosphoglycerate mutase; Eno, 18 
phosphopyruvate hydratase; PEP, phosphoenolpyruvate; AceEF, LpdGV, Lpd3, and AcoA, pyruvate 19 
dehydrogenase; MaeB, malic enzyme; Pyk, pyruvate kinase; Mdh, malate dehydrogenase; Mqo, 20 
malate:quinone oxidoreductase; AccC-2, pyruvate carboxylase subunit A; OadA, pyruvate 21 
carboxylase subunit B; Ppc, PEP carboxylase; FumC, fumarate hydratase; SdhABCD, succinate 22 
dehydrogenase; SucACD and KgdB, succinyl-coenzyme A synthetase and 2-ketoglutarate 23 
dehydrogenase; AcnAB, aconitate hydratase; Icd, isocitrate dehydrogenase; GltA, citrate synthase. 24 
25 
25 
 
 
 
Figure 3. Impact of carbon recycling on energy and redox balances. 1 
 2 
 3 
 4 
 5 
 6 
The action of the EDEMP cycle is illustrated with a theoretical example of flux distribution. The total 7 
carbon uptake is arbitrarily consider to be 100 (arbitrary units), and glucose can be split into the 8 
phosphorylative (f) or oxidative (x) branches, such that f + x = 100. When the system is at a steady 9 
state, the net formation rates of pyruvate, ATP, and NADPH adopt the values indicated in the inset 10 
table, r being the amount of triose phosphates being recycled to hexose phosphates (i.e., recycling 11 
flux). The calculations were made on the assumptions that [i] glyceraldehyde-3-P dehydrogenase is 12 
NAD+ dependent and glucose-6-P dehydrogenase is NADP+ dependent, [ii] pyruvate is the end 13 
product of the lower Embden-Meyerhof-Parnas and Entner-Doudoroff glycolytic pathways, and [iii] the 14 
flux through the 2-ketogluconate loop (which uses NADPH as a cofactor to finally yield 6-15 
phosphogluconate) represents a negligible fraction of the glucose consumed. Abbreviations are as 16 
indicated in the legend to Figure 2. Pi, inorganic phosphate. 17 
